Cargando…

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies

CONTEXT: Bladder recurrences have been reported in 22–47% of patients after surgery for upper urinary tract urothelial carcinoma (UTUC). This collaborative review focuses on risk factors for and treatment strategies to reduce bladder recurrences after upper tract surgery for UTUC. OBJECTIVE: To revi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mertens, Laura S., Sharma, Vidit, Matin, Surena F., Boorjian, Stephen A., Houston Thompson, R., van Rhijn, Bas W.G., Masson-Lecomte, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review – Urothelial Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922921/ https://www.ncbi.nlm.nih.gov/pubmed/36793750 http://dx.doi.org/10.1016/j.euros.2023.01.004

Ejemplares similares

International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
por: Beijert, Irene J., et al.
Publicado: (2023)

Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study
por: Bobjer, Johannes, et al.
Publicado: (2023)

Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
por: Miyake, Makito, et al.
Publicado: (2022)

Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma
por: Hendriks, Nora, et al.
Publicado: (2022)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
por: Dobé, Tom-Régis, et al.
Publicado: (2020)

Prognostic Value of Tumor Size in Patients with Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Ma, Runzhuo, et al.
Publicado: (2022)

Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020)

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
por: Zschäbitz, Stefanie, et al.
Publicado: (2023)

The Association Between Renal Function Decline and the Incidence of Urothelial Carcinoma: A 16-year Retrospective Cohort Study in Taiwan
por: Chuang, Yung-Hsin, et al.
Publicado: (2021)

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis
por: Khalid, Sidra, et al.
Publicado: (2020)

Is a Single Nephrographic Phase Computed Tomography Sufficient for Detecting Urothelial Carcinoma in Patients with Visible Haematuria? A Prospective Paired Noninferiority Comparison
por: Galtung, Kristina F., et al.
Publicado: (2023)

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer
por: Lindskrog, Sia V., et al.
Publicado: (2023)

Intraoperative Mitomycin C Bladder Instillation During Radical Nephroureterectomy Is Feasible and Safe
por: Nadler, Naomi, et al.
Publicado: (2021)

Prediction of Metastatic Patterns in Bladder Cancer: Spatiotemporal Progression and Development of a Novel, Web-based Platform for Clinical Utility
por: Mason, Jeremy, et al.
Publicado: (2021)

STAG2 Protein Expression in Non–muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes
por: Gordon, Naheema S., et al.
Publicado: (2022)

Neoadjuvant chemotherapy for upper tract urothelial carcinoma
por: Kim, Do Kyung, et al.
Publicado: (2020)

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
por: Marcq, Gautier, et al.
Publicado: (2022)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
por: Paciotti, Marco, et al.
Publicado: (2021)

Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes
por: Ko, Young Hwii
Publicado: (2020)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery
por: Soria, Francesco, et al.
Publicado: (2022)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018)

Current status of the focused series “Urothelial Carcinoma”
por: Yuk, Hyeong Dong, et al.
Publicado: (2020)

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020)

UGN-101 (mitomycin gel): a novel treatment for low-grade upper tract urothelial carcinoma
por: Kokorovic, Andrea, et al.
Publicado: (2020)

Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
por: D’Andrea, David, et al.
Publicado: (2020)

Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes
por: Catto, James W.F., et al.
Publicado: (2021)

Outcomes of endoscopic management of upper tract urothelial carcinoma
por: Knoedler, John J.
Publicado: (2020)

Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
por: Petros, Firas G.
Publicado: (2020)

Endoscopic management of upper tract urothelial carcinoma—tips and tricks
por: Shvero, Asaf, et al.
Publicado: (2020)

Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
por: Kaag, Matthew G.
Publicado: (2020)

The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma
por: Goltzman, Michael E., et al.
Publicado: (2020)

Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
por: Smentkowski, Katherine E., et al.
Publicado: (2020)

The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma
por: Kang, Ho Won, et al.
Publicado: (2020)

Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma
por: Metcalf, Meredith, et al.
Publicado: (2020)

An editorial comment for the special series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions”
por: Knoedler, John J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ade5gl4l5roarir6n12qbslvn6